secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sonoma Pharmaceuticals, Inc. (SNOA)
CIK:        0001367083
Form:       8-K
Filed at:   2023-04-13T23:59:59+00:00
Accession:  0001683168-23-002359
Event type: leadership
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sonoma Pharmaceuticals CFO Chad White resigns; Jerry Dvonch named interim CFO
-----------------------------------------------------------------------------

- Chad White resigned as CFO effective April 7, 2023; unvested options forfeited.
- Board appointed Jerry Dvonch (former CFO, Sept 2020–Nov 2022) as interim CFO.
- Dvonch to receive $250/hour plus $30,000 in restricted stock vesting July 15 and Aug 15, 2023.
- Consulting agreement runs until filing of Q1 FY2024 10-Q (quarter ending June 30, 2023).
- Dvonch's vested equity awards extended by one month per month of service under the agreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1367083/000168316823002359/0001683168-23-002359-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1367083/000168316823002359/sonoma_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-23-002359

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer